Sign in
CompletedNo phase

Digital Health Intervention to Support Opioid Use Disorder Treatment

Key facts

Who runs it
Rhode Island Hospital
Where
Providence, United StatesSee the site
Trial code
Status
Completed
People taking part
80 people enrolled
Started
1 Oct 2020
Ended
15 Nov 2023
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • iENDURE
Record updated
10 April 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • age 18+ years; current DSM-5 diagnosis of Opioid Use Disorder; current buprenorphine prescription; and access to cell phone with text message capability

Who cannot take part

  • active suicidality and/or psychosis; not fluent in English; not having a phone data plan

Where in United States

  • Rhode Island HospitalProvidence, United States

About the trial

What the trial wants to find out

In prior studies, the investigative team developed a combined computer- and text message-delivered personalized-feedback intervention (iENDURE) designed to enhance motivation and improve tolerance of distress to support the early phase of buprenorphine treatment. Specific aims of this subsequent study include conducting a preliminary randomized controlled trial with 80 participants to examine the efficacy of iENDURE relative to Treatment-as-Usual (TAU).

The 2 groups in the trial

  • iENDURETreatment being tested

    iENDURE involves two delivery modes: computer and text message. The intervention initially targets motivational processes in combination with introductory strategies for managing physical and emotional distress through a single, brief, computer-delivered session followed by eight weeks of theoretically-informed text messages intended to enhance motivation and promote distress tolerance (DT).

  • Treatment-as-UsualNo study treatment, for comparison

    Participants in the TAU comparison control group will engage in buprenorphine treatment as determined by their clinical team. This could include medication evaluations, individual or group counseling, case management or peer recovery. TAU was selected as the comparison condition as it represents a robust and evidence-based approach to the treatment of OUD.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
iENDURE: Digital Health Intervention to Support Opioid Use Disorder Treatment
Publications
Record updated
10 April 2024